| Risk factors for asthma: is prevention possible? R Beasley, A Semprini, EA Mitchell The Lancet 386 (9998), 1075-1085, 2015 | 593 | 2015 |
| Controlled trial of budesonide–formoterol as needed for mild asthma R Beasley, M Holliday, HK Reddel, I Braithwaite, S Ebmeier, RJ Hancox, ... New England Journal of Medicine 380 (21), 2020-2030, 2019 | 452 | 2019 |
| Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group, randomised … ID Pavord, M Holliday, HK Reddel, I Braithwaite, S Ebmeier, RJ Hancox, ... The Lancet Respiratory Medicine 8 (7), 671-680, 2020 | 101 | 2020 |
| Kanuka honey versus aciclovir for the topical treatment of herpes simplex labialis: a randomised controlled trial A Semprini, J Singer, I Braithwaite, N Shortt, D Thayabaran, M McConnell, ... BMJ open 9 (5), e026201, 2019 | 61 | 2019 |
| Optimal asthma control: time for a new target R Beasley, I Braithwaite, A Semprini, C Kearns, M Weatherall, ID Pavord American Journal of Respiratory and Critical Care Medicine 201 (12), 1480-1487, 2020 | 47 | 2020 |
| Type 2 biomarkers and prediction of future exacerbations and lung function decline in adult asthma R Semprini, M Williams, A Semprini, A McDouall, J Fingleton, C Holweg, ... The Journal of Allergy and Clinical Immunology: In Practice 6 (6), 1982-1988. e1, 2018 | 32 | 2018 |
| ICS-formoterol reliever therapy stepwise treatment algorithm for adult asthma R Beasley, I Braithwaite, A Semprini, C Kearns, M Weatherall, ... European Respiratory Journal 55 (1), 2020 | 31 | 2020 |
| How big is your bubble? Characteristics of self-isolating household units (‘bubbles’) during the COVID-19 Alert Level 4 period in New Zealand: A cross-sectional survey N Kearns, N Shortt, C Kearns, A Eathorne, M Holliday, D Mackle, ... BMJ open 11 (1), e042464, 2021 | 28 | 2021 |
| An Aotearoa New Zealand survey of the impact and diagnostic delay for endometriosis and chronic pelvic pain J Tewhaiti-Smith, A Semprini, D Bush, A Anderson, A Eathorne, ... Scientific reports 12 (1), 4425, 2022 | 27 | 2022 |
| Change in biomarkers of type-2 inflammation following severe exacerbations of asthma R Semprini, N Shortt, S Ebmeier, A Semprini, R Varughese, CTJ Holweg, ... Thorax 74 (1), 95-98, 2019 | 26 | 2019 |
| Randomised controlled trial of topical kanuka honey for the treatment of acne A Semprini, I Braithwaite, A Corin, D Sheahan, C Tofield, C Helm, ... BMJ open 6 (2), e009448, 2016 | 26 | 2016 |
| Medical cannabis: knowledge and expectations in a cohort of North Island New Zealand general practitioners K Oldfield, I Braithwaite, R Beasley, A Eathorne, G Newton-Howes, ... The New Zealand Medical Journal (Online) 133 (1508), 12-5, 2020 | 21 | 2020 |
| Using comics and curiosity to drive pandemic research on a national scale C Kearns, N Kearns, I Braithwaite, N Shortt, A Eathorne, A Semprini, ... Journal of visual communication in medicine 44 (1), 12-22, 2021 | 20 | 2021 |
| Cannabis in palliative care: a systematic review of current evidence M Doppen, S Kung, I Maijers, M John, H Dunphy, H Townsley, A Eathorne, ... Journal of Pain and Symptom Management 64 (5), e260-e284, 2022 | 16 | 2022 |
| Protocol for a randomised controlled trial of 90% kanuka honey versus 5% aciclovir for the treatment of herpes simplex labialis in the community setting A Semprini, J Singer, N Shortt, I Braithwaite, R Beasley BMJ open 7 (8), e017766, 2017 | 11 | 2017 |
| Experiences, patient interactions and knowledge regarding the use of cannabis as a medicine in a cohort of New Zealand doctors in an oncology setting K Oldfield, A Eathorne, J Tewhaiti-Smith, R Beasley, A Semprini, ... Postgraduate Medical Journal 98 (1155), 35-42, 2022 | 9 | 2022 |
| Dose-response relationship of ICS/fast-onset LABA as reliever therapy in asthma R Beasley, J Harper, G Bird, H Dunphy, A Semprini, ID Pavord, A Papi, ... BMC Pulmonary Medicine 19, 1-8, 2019 | 9 | 2019 |
| Cannabis-based medicinal products and the role of the doctor: should we be cautious or cautiously optimistic? I Braithwaite, G Newton-Howes, K Oldfield, A Semprini The New Zealand Medical Journal (Online) 132 (1500), 82-88, 2019 | 9 | 2019 |
| Knowledge and perspectives about the use of cannabis as a medicine: a mixed methods observational study in a cohort of New Zealand general practice patients K Oldfield, A Eathorne, I Maijers, R Beasley, A Semprini, I Braithwaite The New Zealand Medical Journal (Online) 133 (1522), 96-111, 2020 | 8 | 2020 |
| Cannabis-based medicinal products in arthritis, a painful conundrum M John, M Black, A Semprini, K Oldfield, M Glass, I Braithwaite, ... The New Zealand Medical Journal (Online) 133 (1515), 35-5, 2020 | 8 | 2020 |
Richard BeasleyDirector, Medical Research Institute of New ZealandVerified email at mrinz.ac.nz
